AVIR

About Atea Pharmaceuticals, Inc. Common Stock (AVIR) Stock

Atea Pharmaceuticals, Inc. Common Stock (AVIR) closed the 2026-09-17 session at $5.26, up 2.14% versus the previous close (+0.11). The stock opened at $5.21 and traded between $5.20 and $5.33 during that session. Session trading volume was 279K shares. The volume-weighted average price (VWAP) is $5.28.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Atea Pharmaceuticals, Inc. Common Stock has a market capitalization of $421.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. AVIR is listed on the XNAS exchange. The company employs approximately 55 people. Atea Pharmaceuticals, Inc. Common Stock is headquartered in BOSTON, MA. The recorded listing date is 2020-10-30.

On this page you can find market AVIR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.